Parnax Lab

Parnax Lab Net Tangible Assets

The Net Tangible Assets of Parnax Lab (506128.BO) as of Oct 27, 2026 is 822.96 M INR. In the previous year, Net Tangible Assets was 707.83 M INR — a change of 16.26% (higher).

Net Tangible Assets

822.96 MINR

YoY

16.26%

Last updated:

Net Tangible Assets of Parnax Lab is 2025 822.96 M INR. Net Tangible Assets of Parnax Lab was 2024 707.83 M INR. It decreases by 16.26% higher compared to the previous year.

The Parnax Lab Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
322.96 M INR
Jan 1, 2019
354.58 M INR
Jan 1, 2020
325.89 M INR
Jan 1, 2021
324.02 M INR
Jan 1, 2022
480.95 M INR
Jan 1, 2023
619.21 M INR
Jan 1, 2024
707.83 M INR
Jan 1, 2025
822.96 M INR
The Parnax Lab Net Tangible Assets history
YEARNet Tangible AssetsYoY
822.96 MINR+16.26%
707.83 MINR+14.31%
619.21 MINR+28.75%
480.95 MINR+48.43%
324.02 MINR-0.57%
325.89 MINR-8.09%
354.58 MINR+9.79%
322.96 MINR+3.96%
310.66 MINR+12.45%
276.27 MINR+9.98%
251.19 MINR+20.34%
208.73 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Net Tangible Assets of Parnax Lab is 822.96 M INR in 2025.

Net Tangible Assets of Parnax Lab changed from 707.83 M INR to 822.96 M INR, representing a 16.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Parnax Lab

All Key Metrics — Parnax Lab